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Abstract
Background: In our daily experience, the differentiation between a cold and hot nodule is a very important factor
for further clinical management of the patient.
In this study, we compared the characteristics of incidentally found thyroid nodules detected on computed tomography
(CT) to thyroid scintigraphy (TS).
Methods: Diagnostic reports from chest CT with intravenous contrast and TS examinations performed from January
2013 to January 2016 were analyzed retrospectively. We identified 70 subjects: 50 with thyroid nodules and 20 control
subjects without thyroid nodules. The examination time of the TS was a minimum of two to four months after a chest
CT. Chest CTs were performed in the arterial phase after the application of contrast media.
Results: Patients with a cold nodule had a significantly lower Hounsfield Unit (HU) Nodule(N)/Parenchyma (P) ratio
values than the patients with a hot or warm nodule (P < 0.05). The cut-off HU N/P ratio value with the highest sum of
sensitivity and specificity for the prediction of a functioning nodule was 69 (95% CI: 0.79–0.95).
Conclusions: Our results imply that the HU N/P ratio of the thyroid nodule on the chest CT should be taken
into account to assess the functionality of the nodule. A lower HU N/P ratio should alert the radiologist or
nuclear medicine physician to the possibility that the nodule might be cold and thus more prone to malignancy.
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Background
Thyroid scintigraphy (TS) is a nuclear medicine method
that generates a functional depiction of a thyroid based
on the uptake degree of different radionuclides. TS as a
diagnostic procedure helps the physician obtain informa-
tion about the thyroid’s functional state. In addition, it
determines the size, shape, and position of the thyroid
gland. TS can define the degree of function in a thyroid
nodule that is palpable or found incidentally during a
non-nuclear imaging procedure. Hot nodules are more
often benign than cold lesions are. The most commonly
used substance is radioactive technetium-99 m [1–4].
After accumulation in the thyroid gland, gamma radi-
ation is recorded by the gamma camera so that the thy-
roid is presented as an image and the function of the
thyroid may be assessed. Simultaneously, the amount of
radionuclide is measured in the thyroid gland, and the
technetium thyroid uptake (TcTU) is determined.
The thyroid nodule is an anomalous growth of thyroid
cells. Most of the thyroid nodules are benign; a small
portion of thyroid nodules could inclose malignant cells.
Most thyroid nodules cause no noticeable symptoms.
Nodules in the thyroid are mostly found incidentally
during routine physical examinations or during a diag-
nostic modality such as computed tomography (CT) or
sonography, which have to be done for entirely unrelated
reasons. Thyroid nodules could cause hyperthyroidism
due to increased production of thyroid hormones. How-
ever, most thyroid nodules are actually non-functioning.
Thyroid nodules are an extremely common thyroid
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disorder. The frequency of these incidentalomas has
ranged from as low as 2% to as high as 67% [5].
Thyroid incidentaloma is a non-symptomatic lesion
that is detected in a diagnostic modality while evaluating
for non-thyroid-related issues. In the majority of cases,
they are found during ultrasound examinations of the
neck, followed by CT, magnetic resonance imaging
(MRI) and 18 F-Fluor-Desoxyglucose positron emission
tomography (18 F-FDG-PET).
A couple of studies have attempted to evaluate the
diagnostic value of CT to differentiate malignant thyroid
nodule lesions from benign thyroid nodules. In these
studies, the histopathological results have been used as a
reference standard [5]. Davis et al. reported a low possi-
bility of malignancy in these thyroid nodules depending
on other risk factors in their study. The histopatho-
logical results of most of these malignancies were small
papillary carcinomas [6].
Knowing the type of nodule (i.e., cold, hot, or warm) is
critical in the clinical routine. About 13% of cold nodules
have the risk of malignancy [7]. In addition, identifying the
characteristics of the nodule type is also important for fur-
ther thyroid nodule management. Although the presence
of a cold nodule could be due to benign conditions, such
as cysts, macrocalcification, and less commonly, areas of fi-
brosis or changes after thyroiditis, a malign lesion cannot
be excluded. A fine-needle biopsy is often necessary.
The prevalence of incidentally found nodules in the
thyroid has been reported in a couple of mainly CT- and
MRI-based studies. Yoon et al. [8] found incidental nod-
ules in the thyroid nodules in 16% of participants in
their study. They examined 734 patients who were not
known to have thyroid disease using a 16-slice CT scan.
They reported that 9% of the incidentally found thyroid
nodules were malignant. 123 CT scans and 108 MRI
examinations of the neck were used in the study by
Youserm et al. A prevalence of 16% for incidental thy-
roid nodules was reported by this study group [9].
In our daily experience, the differentiation between a
cold and hot nodule is a very important factor for fur-
ther clinical management of the patient. In this study,
we compared the characteristics of incidental thyroid
nodules detected on CT to TS. To our knowledge, this
is the first study that conducts such a comparison.
Methods
Ethical issues
The local ethics committee granted ethical approval for this
study. Informed consent was obtained from all participants.
This study conformed to the Declaration of Helsinki.
Patient selection
We evaluated 70 subjects. In our study, we searched
retrospective chest CT examinations performed from
January 2013 to January 2016 that contained the words
“thyroid nodule” in the diagnostic report. In 50 reports
where one thyroid nodule was diagnosed, the patients
also had TS. We identified and included 50 patients (19
men, 31 women; age range: 51–90 years; mean age:
67 years) in our study. The mean body mass index
(BMI) of the patients was 26, and the mean weight was
68 kg. At the time of the CT and TS examinations, all
patients were unmedicated. No treatment was performed
between the two examinations. In addition, we added 20
control subjects (16 men, 4 women; age range: 52–77
years; mean age: 64 years) without thyroid nodules in
CT and Ultrasound examination. The mean BMI of the
control subjects was 25, and the mean weight was 64 kg.
Patients with cysts, parenchymal changes after surgery,
and radiodine therapy have been excluded. We selected
only patients with one nodule detected incidentally on
chest CT examination.
CT examination protocol
The CT scans were performed with a Brilliance 64-slice
CT scanner (Philips Medical Systems Corporation,
Cleveland, Ohio, USA). The following parameters for
the 64-section multi-detector scanner were used: recon-
structed slice thickness, 3 mm; reconstruction incre-
ment, 2 mm; x-ray tube current, 200 mAs; voltage,
120 kV; and collimation, 6.4 × 0.63 mm. A filtered back
projection reconstruction technique was used.
The chest CT scans were done in the craniocaudal dir-
ection. The iodine contrast material dosage was 300
mgI/kg. The injection flow rate was 2.5 mL/s. The chest
CT was performed during the arterial phase. Both arms
were raised above the shoulder region. No artefacts were
detected in the thyroid region on selected chest CT
examinations. The average radiation dose associated
with chest CT scanning was 7 mSV.
Thyroid scintigraphy
The thyroid scintigraphy in our study was done with Tc-
99-metastable pertechnetate. The scans were performed
with a parallel high-resolution low-energy collimator at
an energy setting of 140 KeV photo peak for Tc-99 m.
The scan was done 20 min after the intravenous admin-
istration of 75–90 MBq Tc-99 m pertechnetate. The
examination time of the TS was a minimum of two to
four months after a chest CT. Nodules are depicted as
zones of increased (hot), identical uptake compared to
the uptake of normal paranodular thyroid tissue (warm)
or decreased (cold) tracer uptake.
Thyroid ultrasound
The US studies were performed with a Toshiba Aplio
XG scanner (Toshiba Medical Systems, Tokyo, Japan)
using an 18 MHz convex probe. The examinations of
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the patients were performed in the supine position. To
locate the thyroid and to evaluate the thyroid nodule
echogenicity, the real-time B-mode ultrasonography was
used. The echogenicity of the nodule was reported as
isoechoic, hypoechoic, or hyperechoic in relation to the
thyroid parenchymal glands. The echotexture was de-
scribed as homogeneous or heterogeneous. The US
examination was performed on the same day as the thy-
roid scintigraphy.
Image analysis
We have used our picture archiving and communication
system (PACS) to fetch the CT images and transfer them
to a standard viewer (Sectra; Version 15.2.4.1, Sweden).
Two circular regions of interest (ROI) (5 mm) were
placed in the center of the thyroid lesion, and another
two ROI were placed in the thyroid normal parenchyma
(5 mm) (Fig. 1). All chest CT studies were reviewed by a
radiologist with 10 years of experience in chest imaging.
We determined the HU density nodule to parenchyma
ratio (HU N/P ratio) for two ROI in the thyroid nodule.
We also determined the HU density nodule to control
subject’s parenchyma ratio (HU N/P-control ratio) for
two ROI in the thyroid nodule, and another two ROI
were placed in the thyroid normal parenchyma.
Statistical analysis
All data were recorded in a Microsoft Excel file, and the
statistical analysis was conducted using SPSS (Version 22,
IBM, USA) and ACOMED Statistic (Version 1, ACOMED,
Germany) software. The results are presented as a box plot.
For quantitative analysis, we performed independent
tests to estimate the differences in our results. To calcu-
late the optimal cut-off value to maximize the sum of
sensitivity and specificity and to estimate the area under
the curve (AUC), receivers operating characteristic curve
(ROC) analyses have been performed. Probability values
of less than 0.05 were considered significant.
Results
The study included 50 patients with chest CT and a thy-
roid incidentaloma.
The mean thyroid nodule size was 21 mm (min 11,
max 50) on the CT of the chest in the axial plane. The
hot nodules had a mean size of 22 mm, and the cold
nodules had a mean size of 24 mm. The warm nodules
had a mean size of 21 mm measured in the axial plane.
Hypofunctional nodules with diminished uptake (cold
nodule) were seen in 20 patients (40%) (Fig. 2). Twenty-
three patient (46%) showed a moderate uptake (warm
nodule) on a Tc-99 m-Thyroid scan. Excessive uptake of
Tc-99 m-pertechnetate was seen in 7 patients (14%) as
defined by a hot nodule (Fig 3a, b).
On the ultrasound examination, the cold nodules were
hypoechoic in 11 patients, isoechoic in 6 patients, and
hyperechoic in 3 patients. The warm nodules were isoe-
choic in 12 patients, hypoechoic in 10 patients, and
hyperechoic in 1 patient. Four of the patients with hot
nodules were hypoechoic, and three were isoechoic.
The mean TSH value for patients with a cold nodule
at the time of TS was 1.5 ± 1. Patients with a warm nod-
ule had a mean TSH value of 2.2 ± 2 and with a hot
nodule, a value of 0.8 ± 1.
Histopathalogy results of cold nodules from 16 pa-
tients revealed 2 patients with thyroid carcinoma, 1 with
anaplastic carcinoma, and 1 with papillary carcinoma. In
2 cases inflammatory cells were present, and in 10 pa-
tients the results were compatible with non-malignant
adenoma. Two patients with a cold nodule refused sur-
gery and FNA. Only 4 patients with hot or warm nod-
ules had biopsies indicative of non-malignant adenoma.
Cold nodules had a median 56 HU value on the chest
CT. A median HU of 89 was detected for warm nodules
on the chest CT. Hot nodules showed a median value of
86 HU on the chest CT examination. Cold nodules had
a mean HU N/P ratio value of 56 ± 22 on the chest CT.
A mean HU N/P ratio of 87 ± 20 was detected for warm
Fig. 1 The CT image shows two ROIs in the thyroid nodule. Abbreviations: CT, computed tomography; ROI, region of interest
Zandieh et al. BMC Medical Imaging  (2017) 17:8 Page 3 of 7
Fig. 2 TS shows an area with diminished uptake in the right lobe of the thyroid laterocaudal which is consistent with a cold nodule. Abbreviations: TS,
Thyroid scintigraphy
Fig. 3 a, b TS shows an area with increased uptake in the right lobe of the thyroid caudal which is consistent with a hot nodule The chest CT
depicts a nodule in the right lobe of the thyroid. Abbreviations: TS, Thyroid scintigraphy; CT, computed tomography
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nodules on the chest CT. Hot nodules showed a
mean value of 86 ± 14 HU N/P ratio on the chest CT
examination. The HU N/P ratio values were signifi-
cantly lower in patients with cold nodules than the
other groups (P < 0.05) (Table 1) (Fig. 4).
Cold nodules had a mean HU N/P-control ratio value
of 64 ± 25 on the chest CT. A mean HU N/P-control ra-
tio of 94 ± 21 was detected for warm nodules on the
chest CT. Hot nodules showed a mean value of 102 ± 16
HU N/P-control ratio on the chest CT examination. The
HU N/P-control ratio values were significantly lower in
patients with cold nodules than in the subjects of the
other groups (P < 0.05).
The optimal cut-off HU N/P ratio value for which the
sum of sensitivity and specificity was highest for the pre-
diction of a functioning nodule (warm or hot) was 69
(95% CI: 0.79–0.95). For this cut-off value, HU N/P ratio
value had a sensitivity of 89% and a specificity of 83%.
To obtain a sensitivity > 90%, the best cut-off value was
65 (95% CI: 0.79–0.95) (94% sensitivity, 78% specificity)
(Fig. 5) [10].
Discussion
Thyroid incidentaloma is an unintentional finding that is
not related to the original reason for performing a CT
study. In the last decade, the evolution of diagnostic
techniques has significantly improved diagnoses in endo-
crine thyroid disease.
The challenge facing the clinician is to avoid unneces-
sary diagnostic intervention, treatment, or both [11].
Frank et al. reported in a systematic review of 11 chest
CT studies that had been performed for coronary artery
disease and lung cancer screening had revealed that the
proportion of patients with at least one incidental im-
aging abnormality requiring follow-up varied from 3% to
41.5% [12].
Thyroid abnormalities, such as nodules, cysts, calcifica-
tions, and diffuse glandular enlargement, are often de-
tected on chest CT examinations. Thyroid nodules are
found in approximately 16% of chest CT scans, occurring
more commonly in women than men. Most incidentally
found thyroid lesions are benign, with an approximately
9% to 11% prevalence of malignant lesions [12].
Once an incidental thyroid nodule is found, referral to
a thyroid specialist is necessary. According to American
Thyroid Association (ATA) guidelines, generally, only
nodules >1 cm need further evaluation because they
have a greater potential to represent clinically significant
cancers compared with lesions <1 cm and because of
cost/benefit considerations regarding the work-up of
small nodules.
According to Austrian clinical guidelines, after detec-
tion of a thyroid nodule of over 1 cm, radionuclide im-
aging should be performed to characterize the thyroid
nodule. If a nodule is cold, fine needle aspiration will be
performed; otherwise, the nodule will be monitored on
ultrasound besides there is a growth of the warm or hot
nodule in the follow-up ultrasound examinations or
FNA is recommended duo to the ATA guidelines. In
radionuclide imaging, only 4% of hot nodules are known
to contain malignant cells, compared with 16% of cold
nodules [13].
Our results show no correlation between thyroid nod-
ule functionality and US echogenicity. There was no cor-
relation between the size of the thyroid nodule and
functionality. The BMI values of the patient and the
neck circumference measurements have no correlation
to the thyroid nodule functionality.
Small amounts of free iodide are contained in an io-
dinated contrast medium. A 200-ml dose of a contrast
medium containing 35 μg/ml provides 7,000 μg free iod-
ide, equivalent to 45 times the recommended daily in-
take [14]. Our hypothesis was that iodine containing
contrast media for chest CT accumulates in the thyroid
due to the act of iodination, and this process could influ-
ence the HU values of the thyroid.
No CT feature is reliable in distinguishing cold from
warm or hot thyroid lesions. In our study we tried to
find a difference between the contrast uptakes of the
thyroid nodule as detected incidentally by computed
tomography and the degree of function of the same thy-
roid nodule on thyroid scintigraphy. Our data illustrate
that there is a significant difference between the assess-
ments, particularly, in the HU N/P ratio of the cold nod-
ule to the hot or warm nodule. An HU N/P ratio values
lower 69 should alert the radiologist of the presence of a
cold nodule.
In addition, the results of the determination of the
HU density nodule to control subject’s parenchyma
ratio in our study were significantly lower in patients
with cold nodules than in the subjects of the other
groups.
Table 1 Characteristics of CN, WN and HN detected incidentally on chest CT
Patient Mean size on CT Isoechogenic Hypoechogenic Hyperechogenic HU N/P ratio median
CN 20 (40%) 24 mm 6 11 3 56 ± 22
WN 23 (46%) 21 mm 12 10 1 87 ± 20
HN 7 (14%) 22 mm 3 4 0 86 ± 14
Abbreviations: CN cold nodule; WN warm nodule; HN hot nodule; CT computed tomography
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Patients who have been referred to a thyroid specialist
to diagnose the thyroid nodule could have had a prior
chest CT for other reasons.
ATA and ETA (European Thyroid Association) guide-
lines suggest that nodules that are "hot or warm on scin-
tigraphy" do not require a biopsy.
Our results suggest that the HU N/P ratio of the thy-
roid nodule on a chest CT should be taken into account
to assess the functionality of the nodule before using
thyroid scintigraphy. With further studies in the future,
it may not be necessary to perform a TS in this context,
which would avoid unnecessary radiation exposure and
reduce costs.
In addition to the ultrasound characteristic of the nod-
ule, a lower HU N/P ratio should alert thyroid specialists
to the possibility that the nodule might be cold and thus
more prone to malignancy, even using ATA and ETA
guidelines for handling incidentalomas. In such cases,
the biopsy could be done earlier.
In the study of Basharat et al., where a comparison was
made between the results of TS and histopathology, the
overall sensitivity on the TS was found to be 80%, specifi-
city was 20%, positive predictive value was 10%, and nega-
tive predictive value was 90%. The overall accuracy was
26% [15]. In one study of TS, it was reported that the sen-
sitivity was 100% and that the specificity was 24% [16].
False-positive TS is rare. Some artifacts and physio-
logic variants are known to consistently take up Tc-99-
metastable pertechnetate, but these are easily discounted
by experienced nuclear medicine physicians [17, 18].
Limitations of the study included a lack of pathological
results and differentiation between benign and malignant
thyroid nodules; however, these were not relevant to the
aim of the study. Another limitation is calcification. This
should not be captured in the ROI in order to avoid sus-
taining inadequate HU N/P ratio values. In our study,
both arms were raised above the shoulder region. We
have not included data about other arm positions.
Therefore, further studies are necessary to determine the
optimal cut-off HU N/P ratio for other arm positions.
Fig. 4 Boxplot graphics of HU N/P ratio values of CN, WN and HN. The HU N/P ratio values were lower in CN than to WN and HN (P < 0.05).
Abbreviations: HU N/P ratio, Hounsfield Unit Nodule/Parenchyma ratio; CN, cold nodule; WN, warm nodule; HN, hot nodule
Fig. 5 The ROC curve of the HU N/P ratio values assessed in patients
with thyroid nodule. Abbreviations: ROC, Receiver Operating
Characteristic; HU N/P ratio, Hounsfield Unit Nodule/Parenchyma ratio
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We believe that with further studies, the guidelines
could be reconsidered in the future.
Conclusions
Our results imply that the HU N/P ratio of the thyroid
nodule on the chest CT should be taken into account to
assess the functionality of the nodule. A lower HU N/P
ratio should alert the radiologist or nuclear medicine
physician to the possibility that the nodule might be cold
and thus more prone to malignancy, even using ATA
and ETA guidelines for handling incidentalomas.
Abbreviations
18 F-FDG-PET: 18 F-Fluor-Desoxyglucose positron emission tomography;
ATA: American Thyroid Association; AUC: Area under the curve; CT: Computed
tomography; ETA: European Thyroid Association; HU: Hounsfield Unit;
MRI: Magnetic resonance imaging; PACS: Picture archiving and communication
system; ROC: Receivers operating characteristic curve; ROI: Regions of interest;
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